InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the full record of transactions filed by DiRaimondo Thomas, Chief Scientific Officer. Insider active across 1 companies, notably Janux Therapeutics, Inc.. Cumulatively, 2 disclosures have been recorded. Total volume traded: €59k. The latest transaction was filed on 2 January 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations2 total
US$29,2702,505 shares@ US$11.68460.0035% mcap100.0% of flow
Common Stock
SEC:0002005618-26-000002·
€29,2702,505 shares@ €11.68460.0035% mcap50.0% of flow
Common Stock
SEC:0002005618-26-000002:0·
2 of 2 declarations
About DiRaimondo Thomas
Thomas DiRaimondo is the Chief Scientific Officer at Janux Therapeutics, Inc. He oversees the company's research and development initiatives, contributing to innovation and scientific advancement. His expertise is essential for Janux.
